Search NLS News

Immunovia has announced the successful completion of the CLARITI study, (Clinical Validation of Next-Generation Test for Early-Stage Pancreatic Cancer) to detect early-stage pancreatic ductal adenocarcinoma (PDAC).

The European Medicines Agency (EMA) has granted Advanced Therapy Medicinal Product (ATMP) classification to NEOGAP's cell therapy, pTTL (personalized Tumor Trained Lymphocytes).

The first dose has been administered in the company’s Phase II clinical study evaluating the drug candidate sevuparin for the treatment of chronic kidney disease (CKD) with associated anemia.

The board has decided to terminate CEO Per Norlén's employment.

When it comes to life science, one of the strengths of Norway and the Nordics is basic and translational immunology. This is where researchers engineer cells and soluble proteins with the aim of developing new strategies to treat diseases, such as autoimmunity and cancer. 

Cellevate has appointed Jennifer Valdes as Vice President of Sales & Marketing for the North American market.

MetaCurUm has been awarded SEK 1 million from the Swedish Innovation Agency, Vinnova, under the "Acceleration of Deeptech Companies 2024" initiative.

In this year’s Nobel Week Dialogue, Nobel Prize laureates and other experts will gather to discuss and envision our future.

The 2024 Nobel Prizes in Chemistry and Physics reflect the revolutionary impact of artificial intelligence (AI) on life sciences. These awards, celebrating advancements in protein design and neural networks, demonstrate how AI is transforming how we approach drug discovery, personalized medicine, and healthcare management.

AstraZeneca has announced the appointment of Iskra Reic as Executive Vice President (EVP), International with responsibility for overall strategy and driving sustainable growth across this broad region.